Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the terms of the agreement, iBio obtained an exclusive license to Planet’s ACE2-Fc. Planet is eligible to receive certain pre-specified payments upon achievement of clinical development milestones.
Lead Product(s): ACE2-Fc
Therapeutic Area: Infections and Infectious Diseases Product Name: ACE2-Fc
Highest Development Status: PreclinicalProduct Type: Large molecule
Partner/Sponsor/Collaborator: iBio
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement August 28, 2020